ADVISORY, Aug. 18, 2011 (GLOBE NEWSWIRE) - What:Anthera Pharmaceuticals, Inc. (ANTH), a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases, will visit the NASDAQ MarketSite in New York City's Times Square.
